Apart from its established role in chronic myeloid leukemia, studies have also suggested that amplification or overexpression of Abl1 and Abl2 is related to different carcinomas and related to solid tumors (Greuber et al. 2013). The gene discussed is ABL2; the disease is carcinoma.